Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber, MJ Ramsbottom… - Journal of …, 2006 - Elsevier
Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were studied in
patients with relapsing MS that had not responded optimally to standard immunomodulatory …
被引用次数：542 相关文章

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.

AH Cross, JL Stark, J Lauber… - Journal of …, 2006 - europepmc.org
Abstract Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were
studied in patients with relapsing MS that had not responded optimally to standard …
[HTML] nih.gov

[HTML][HTML] Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber… - Journal of …, 2006 - ncbi.nlm.nih.gov
Abstract Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were
studied in patients with relapsing MS that had not responded optimally to standard …

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber, MJ Ramsbottom… - Journal of …, 2006 - infona.pl
Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were studied in
patients with relapsing MS that had not responded optimally to standard immunomodulatory …

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber… - Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were studied in
patients with relapsing MS that had not responded optimally to standard immunomodulatory …

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber… - Journal of …, 2006 - profiles.wustl.edu
Abstract Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were
studied in patients with relapsing MS that had not responded optimally to standard …
[PDF] academia.edu

[PDF][PDF] Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Crossa, JL Starka, J Laubera, MJ Ramsbottoma… - J …, 2006 - academia.edu
Abstract Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were
studied in patients with relapsing MS that had not responded optimally to standard …

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber… - Journal of …, 2006 - jni-journal.com
Abstract Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were
studied in patients with relapsing MS that had not responded optimally to standard …

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH Cross, JL Stark, J Lauber, MJ Ramsbottom… - Journal of …, 2006 - infona.pl
Effects of B cell depletion by rituximab, a monoclonal antibody to CD20, were studied in
patients with relapsing MS that had not responded optimally to standard immunomodulatory …

[引用][C] Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

AH CROSS, JL STARK, J LAUBER… - Journal of …, 2006 - Elsevier